Richmond, CA, United States of America

Dale R Cameron


Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 716(Granted Patents)


Location History:

  • Rosemere, CA (2001 - 2003)
  • Vancouver, CA (2008)
  • Laval, CA (2010 - 2011)
  • Richmond, CA (2004 - 2019)
  • Richmond, CA (US) (2016 - 2020)

Company Filing History:


Years Active: 2001-2020

Loading Chart...
27 patents (USPTO):Explore Patents

Title: The Innovative Journey of Dale R Cameron

Introduction: Dale R Cameron, based in Richmond, CA, is a prolific inventor with an impressive portfolio of 27 patents. His work primarily focuses on the development of therapeutic compounds targeting Granzyme B, which plays a critical role in various diseases. Dale's achievements reflect his commitment to pioneering research in medicinal chemistry.

Latest Patents: Among Dale's most recent patents are the inventions related to cyclic urea compounds and indoline compounds as Granzyme B inhibitors. The cyclic urea compounds patent details compositions that include these compounds and methods for their application in treating conditions such as cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus. The indoline compounds patent emphasizes their advantageous water solubility and effective inhibition of Granzyme B, showcasing Dale's innovative approach to drug development.

Career Highlights: Throughout his career, Dale has collaborated with various leading pharmaceutical companies, including Boehringer Ingelheim (Canada) Ltd. and Vida Therapeutics Inc. His extensive experience in these organizations has significantly contributed to the field of medical research.

Collaborations: Dale has had the opportunity to work alongside talented professionals such as Youla S Tsantrizos and Anne-Marie Faucher. These collaborations have played a pivotal role in the development of innovative therapies and have enriched the scientific community with their combined expertise.

Conclusion: Dale R Cameron's contributions to the field of medicinal chemistry and his dedication to innovation are evident in his significant patent portfolio. His groundbreaking work in developing Granzyme B inhibitors continues to pave the way for advancements in treating challenging medical conditions, highlighting the importance of collaboration and creativity in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…